The EMBO Journal
 
Advanced search
Journal home
Current issue
Advance Online Publication
Web Focuses
Archive
Browse by subject
Free online sample issue
Aims and scope
Press releases
ToC by email
Authors & Referees
Guide for authors
Submit an Article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
The EMBO Journal (2000) 19, 5406–5417, doi:10.1093/emboj/19.20.5406
Steroid-induced androgen receptor–oestradiol receptor beta–Src complex triggers prostate cancer cell proliferation
Antimo Migliaccio1, Gabriella Castoria1, Marina Di Domenico1, Antonietta de Falco1, Antonio Bilancio1, Maria Lombardi1, Maria Vittoria Barone2, Donatella Ametrano1, Maria Stella Zannini3, Ciro Abbondanza1 and Ferdinando Auricchio1
3 Istituto di Patologia Generale e Oncologia, Facoltà di Medicina e Chirurgia, II Università di Napoli, Largo S. Aniello a Caponapoli 2, 80138 Napoli, Italy
1 Dipartimento di Biologia e Patologia Cellulare e Molecolare 'L. Califano', Via Pansini 5, 80131 Napoli Italy
2 Stazione Zoologica 'Anton Dohrn', vl Acquario 1, 80144 Napoli, Italy

To whom correspondence should be addressed
Ferdinando Auricchio, ferdinando.auricchio@unina2.it

Received 2 June 2000; Revised 9 August 2000; Accepted 25 August 2000.
Abstract
Treatment of human prostate carcinoma-derived LNCaP cells with androgen or oestradiol triggers simultaneous association of androgen receptor and oestradiol receptor beta with Src, activates the Src/Raf-1/Erk-2 pathway and stimulates cell proliferation. Surprisingly, either androgen or oestradiol action on each of these steps is inhibited by both anti-androgens and anti-oestrogens. Similar findings for oestradiol receptor alpha were observed in MCF-7 or T47D cells stimulated by either oestradiol or androgens. Microinjection of LNCaP, MCF-7 and T47D cells with SrcK- abolishes steroid-stimulated S-phase entry. Data from transfected Cos cells confirm and extend the findings from these cells. Hormone-stimulated Src interaction with the androgen receptor and oestradiol receptor alpha or beta is detected using glutathione S-transferase fusion constructs. Src SH2 interacts with phosphotyrosine 537 of oestradiol receptor alpha and the Src SH3 domain with a proline-rich stretch of the androgen receptor. The role of this phosphotyrosine is stressed by its requirement for association of oestradiol receptor alpha with Src and consequent activation of Src in intact Cos cells.
Keywords: androgen receptor, cross-talk, oestradiol receptor, Src association
Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2000 by the European Molecular Biology Organization